Citeline Clinical’s Post

From supply chain efficiency to patient-centric value chain: the CRDMO advantage. In this webinar with Thermo Fisher Scientific you will learn: ✔️ How intentional CDMO/CRO partnerships are the key to forging a future that's inherently patient-centric ✔️ The critical role of the supply chain in clinical studies and the role of the clinical site in the value chain ... and so much more. ✔️✔️✔️ Register now: https://ow.ly/HBMU50RtzXk. #DrugDevelopment #CDMO #SupplyChain #Pharmaceuticals

From supply chain efficiency to patient-centric value chain: the CRDMO advantage. In this webinar with Thermo Fisher Scientific you will learn: ✔️ How intentional CDMO/CRO partnerships are the key to forging a future that's inherently patient-centric ✔️ The critical role of the supply chain in clinical studies and the role of the clinical site in the value chain ... and so much more. ✔️✔️✔️ Register now: https://ow.ly/HBMU50RtzXk. #DrugDevelopment #CDMO #SupplyChain #Pharmaceuticals

From supply chain efficiency to patient-centric value chain: the CRDMO advantage. In this webinar with Thermo Fisher Scientific you will learn: • How intentional CDMO/CRO partnerships are the key to forging a future that's inherently patient-centric • The critical role of the supply chain in clinical studies and the role of the clinical site in the value chain ... and so much more. Register now: https://ow.ly/HBMU50RtzXk. #DrugDevelopment #CDMO #SupplyChain #Pharmaceuticals

Our recent webinar, “The #CRDMO advantage,” discussed how strategic partnerships between #CDMOs and #CROs are transforming the #pharmaceutical #supplychain into a patient-centric value chain. Featuring takeaways from industry experts Tara Dougal from Informa Markets and Brenda Bruker and Melinda Santikham from Thermo Fisher Scientific, the event highlighted the following: - Insights from the 2023 report “The nexus between patient and big pharma” - Importance of intentional CDMO/CRO collaborations for patient-centricity - How to optimize integrated CRDMOs to streamline development pathways - The role of the supply chain and clinical sites in enhancing patient care - Methods to help mitigate supply chain disruptions in clinical operations Watch the on-demand recording to discover how #CDMO/#CRO collaborations can help streamline #drugdevelopment and accelerate the delivery of safe, effective, high-quality treatments to patients. Watch it here: http://spr.ly/60415kyqb

The Evolving Landscape of Parenteral Drug Administration: Market Trends Shaping the Future Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market. Join PCI Pharma Services in discovering key trends shaping this market: https://hubs.li/Q02nNXpW0 Sponsored by PCI Pharma Services

Our recent webinar details how Thermo Fisher’s integrated CDMO/CRO clinical delivery model can accelerate clinical trials and drive patient centricity. Watch it now on-demand! 🥳

If you missed our recent webinar "The CRDMO Advantage: From supply chain efficiency to patient-centric value chain", be sure to watch it on-demand using the link provided below!

🧬 Join Almac Diagnostic Services to explore the vital collaboration between diagnostic providers and pharmaceutical/biotechnology companies in developing companion diagnostics (CDx). Aligning strategic approaches is crucial for achieving shared clinical, regulatory, and commercial goals, while considering the program's risk profile. Industry expert, Laura N. sharing recommendations on optimizing the diagnostic-pharma partnership and tackling the challenges of CDx development. Gain insights into managing CDx programs from a diagnostic provider's perspective. 🔍 Register now for actionable insights into managing partnerships with pharma and biotech partners in CDx development: https://buff.ly/4dl7BmD #Genomics #ClinicalSupplyChain #CommercialManufacturing #RegulatorySubmission #BiologicsManufacturing #CellAndGeneTherapies #CDMO

Our recent webinar, “The #CRDMO advantage,” discussed how strategic partnerships between #CDMOs and #CROs are transforming the #pharmaceutical #supplychain into a patient-centric value chain. Featuring takeaways from industry experts Tara Dougal from Informa Markets and Brenda Bruker and Melinda Santikham from Thermo Fisher Scientific, the event highlighted the following: - Insights from the 2023 report “The nexus between patient and big pharma” - Importance of intentional CDMO/CRO collaborations for patient-centricity - How to optimize integrated CRDMOs to streamline development pathways - The role of the supply chain and clinical sites in enhancing patient care - Methods to help mitigate supply chain disruptions in clinical operations Watch the on-demand recording to discover how #CDMO/#CRO collaborations can help streamline #drugdevelopment and accelerate the delivery of safe, effective, high-quality treatments to patients. Watch it here: http://spr.ly/60485kyxC

Looking forward to the upcoming Drugs That Will Shape 2024 webinar with FirstWord Pharma, sponsored by Avalere Health! Join us to learn more about the trends that are anticipated across the industry this year. Register now: https://lnkd.in/eBBj3U4r #AvalereHealth #Pharma2024 #AvalereHealthTrends